Clinical Validation of Risk Stratification Criteria for Peripartum Hemorrhage

2013 ◽  
Vol 122 (1) ◽  
pp. 120-126 ◽  
Author(s):  
Andrew J. Dilla ◽  
Jonathan H. Waters ◽  
Mark H. Yazer
2015 ◽  
Vol 21 (11) ◽  
pp. 2591-2600 ◽  
Author(s):  
Peter Blume-Jensen ◽  
David M. Berman ◽  
David L. Rimm ◽  
Michail Shipitsin ◽  
Mathew Putzi ◽  
...  

2021 ◽  
Vol 2 (2) ◽  
pp. 135-146
Author(s):  
Michiya Nishino ◽  
Claudio Bellevicine ◽  
Zubair Baloch

The past decade has witnessed significant advances in the application of molecular diagnostics for the pre-operative risk-stratification of cytologically indeterminate thyroid nodules. The tests that are currently marketed in the United States for this purpose combine aspects of tumor genotyping with gene and/or microRNA expression profiling. This review compares the general methodology and clinical validation studies for the three tests currently offered in the United States: ThyroSeq v3, Afirma GSC and Xpression Atlas, and ThyGeNEXT/ThyraMIR.


2019 ◽  
Vol 25 ◽  
pp. 287
Author(s):  
Andreea Borlea ◽  
Dana Stoian ◽  
Adrian Apostol ◽  
Mihnea Derban ◽  
Laura Cotoi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document